Enzo Biochem, Inc.
ENZB
$0.4899
-$0.0001-0.02%
OTC PK
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 49.85% | 48.97% | -123.30% | 80.11% | 72.96% |
| Total Depreciation and Amortization | 19.10% | 18.15% | -34.32% | -47.99% | -57.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 232.56% | -82.07% | 104.34% | 120.71% | 50.19% |
| Change in Net Operating Assets | 77.04% | 32.93% | 82.03% | -115.99% | -209.18% |
| Cash from Operations | 77.33% | 32.78% | 93.63% | 43.37% | -44.21% |
| Capital Expenditure | -180.00% | -76.38% | 78.53% | 78.53% | 97.12% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -180.00% | 1,892.13% | -100.12% | 78.53% | 97.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 27.45% | 82.41% | 99.14% | 64.52% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 65.10% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -24,100.00% | 61.39% | 14.88% | -101.34% | 64.52% |
| Foreign Exchange rate Adjustments | -194.74% | 110.00% | 120.65% | -238.46% | -60.42% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 17.04% | 67.27% | -106.00% | -27.37% | -26.62% |